Product Life France
Product Life France is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A first-in-human, two-part, open-label, clinical study to assess the safety, tolerability, and activity of intravenous doses of ICT01 as monotherapy and in combination with an immune checkpoint inhibitor, in patients with advanced-stage, relapsed/refractory cancer (EVICTION Study)
Sponsor Imcheck Therapeutics
- Start (EU)
- Latest update
- Estimated end
Double-blind placebo-controlled clinical trial (Phase 1b/2a) to evaluate safety and efficacy of IM-250 administration in patients with recurrent genital herpes.
Sponsor Innovative Molecules GmbH
- Start (EU)
- Latest update
- Estimated end
- Not reported
A global multicenter phase 1/2 trial of EO2463, a novel microbial-derived peptide therapeutic vaccine, as monotherapy, and in combination with lenalidomide and rituximab, for treatment of patients with indolent Non-Hodgkin's Lymphoma.
Sponsor Enterome
- Start (EU)
- Latest update
- Estimated end
A Phase I/Ib, open-label, dose finding study to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of OBT076, a CD205-directed antibody-drug conjugate, in recurrent and/or metastatic CD205-positive solid tumors
Sponsor Oxford Biotherapeutics Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Product Life France?
The 2026-10-09 snapshot links Product Life France to 4 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Pharmacovogolance, Project management, Regulatory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Product Life France?
The most frequently recorded therapeutic areas are Dermatology, Gastroenterology, Gynecology, Haematological Malignancies. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Product Life France conducted?
The linked trials record locations in 8 countries, including Spain, France, Belgium, Bulgaria, Germany. These are trial locations, not confirmed office locations or countries where Product Life France delivered services.
What can this page tell me about Product Life France's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Product Life France. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Product Life France